Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study

20260 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov identifier, NCT03796858.

Good health and well-being

Published in: Rheumatology and Therapy

Volume 13, Issue 2, pp. 347-360

Field-Weighted Citation Impact: 0.00